Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 10/20 | 0.38 |
| ▸ | PGR | P06401 | 2/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.34 |
| ▸ | ACP1 | P24666 | 1/20 | 0.33 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.33 |
| ▸ | NSD2 | O96028 | 1/20 | 0.32 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24370162 | 0.96 | AR (0.36) | ARPGRPDK2KIF11PTGER4 | |
| SCHEMBL24370445 | 0.92 | KIF11 (0.38) | ARPGRPDK2KIF11PTGER4 | |
| SCHEMBL22985060 | 0.92 | AR (0.38) | ARPGRPDK2KIF11PTGER4 | |
| SCHEMBL24370070 | 0.92 | KIF11 (0.36) | ARPGRPDK2KIF11PTGER4 | |
| SCHEMBL22985608 | 0.91 | AR (0.39) | ARPGRPDK2KIF11PTGER4 | |
| SCHEMBL24370163 | 0.91 | KIF11 (0.36) | ARPGRKIF11PTGER4 | |
| SCHEMBL22985323 | 0.91 | KIF11 (0.39) | ARPGRPDK2KIF11PTGER4 | |
| SCHEMBL24369956 | 0.91 | KIF11 (0.37) | ARPGRPDK2KIF11PTGER4 | |
| SCHEMBL24370446 | 0.91 | AR (0.37) | ARPGRPDK2KIF11PTGER4 | |
| SCHEMBL22985410 | 0.91 | KIF11 (0.41) | ARPGRPDK2KIF11PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220131080-A1 | CARBAZOLE DERIVATES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220131080-A1 | CARBAZOLE DERIVATES FOR USE IN OPTOELECTRONIC DEVICES | SIK3, ORAI3, HIPK3 | AR 4858/4885PGR 4682/4885PDK2 1675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.